CATALYST PHARMACEUTICALS, INC.
Advancing therapies for rare neuromuscular and neurological diseases like LEMS.
CPRX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US14888U1016
- LEI:
- Country:
- United States of America
- Address:
- 355 ALHAMBRA CIRCLE, 33134 CORAL GABLES
- Website:
- https://catalystpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients with rare and debilitating diseases. The company is dedicated to addressing unmet medical needs, particularly within the neuromuscular and neurological therapeutic areas. A primary focus of its commercial efforts is providing treatment for Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder. Catalyst's business model centers on acquiring and advancing therapies to provide effective treatments for underserved patient populations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CATALYST PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CATALYST PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CATALYST PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
